Merck to acquire Imago BioSciences in deal worth $1.35bn pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Imago BioSciences Appoints Enoch Kariuki to Board of Directors
Imago BioSciences Appoints Enoch Kariuki to Board of Directors
Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today announced that its board has appointed a new independent director, Enoch Kariuki, PharmD., who most recently served as the chief financial officer of VelosBio. Enoch comes to Imago with significant expertise in capital formation, business development and finance, and Im delighted to strengthen our board with his addition, said Hugh Rienhoff, Jr., M.D., chief executive officer, Imago BioSciences. His perspective as both an investor and executive in the biotechnology field will provide our board with valuable insights to propel Imago through its upcoming corporate and clinical development milestones.